Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruconest hypersensitivity skin testing and challenge in adults with cow's milk and/or rabbit allergy
NL-OMON20337Active, not recruiting
- Sponsor
- Pharming Group
- Start
- Apr 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of c1-esterase inhibitor in hereditary angioedema (HAE) (2 cohorts), sponsored by Pharming Group. Primary endpoints: Negative predictive value of skin testing, Positive skin reaction rate and 1 more. Started Apr 2012; status: active, not recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NL-OMON20337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20337.